Aveva Drug Delivery Systems Is A Global Leader In Transdermal Drug Deliverybased In Miramarfloridathe Company Specializes In Providing Pharmaceutical Partners With Fully Integratedcontrolled Release Transdermal Products That Address Unmet Market Needs And Offer High Qualityaffordable Alternatives The Company Offers A Wide Range Of Servicesincluding Researchdevelopmentand Manufacturing Of Both Proprietary And Generic Transdermal Systemsaveva Focuses On Creating Customized Solutions Tailored To The Specific Requirements Of Each Chemical Entityenhancing Compounds And Supporting R&D Pipelines For Pharmaceutical Companiestheir Products Aim To Improve Patient Quality Of Life And Compliance Rates Across Various Therapeutic Categories In April 2023Aveva Was Acquired By Difgen Pharmaceuticals Llcthe Company Reported An Annual Revenue Of $96 Million In 2024 And Employs Approximately 149 People
